Gregory J. Divis, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 100,000 shares at $2.05 ($205K) on 2022-05-27, disclosed to the SEC on 2022-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 50,000 | $102K | 50.0% |
| 2 | $2.05 | 50,000 | $103K | 50.0% |
| Total | $2.05 avg | 100,000 | $205K | 100% |
| Filing → |
| AVDL | BUY | 2020-08-13 | $101K | — | Filing → |